Jul 3 |
Company News for Jul 3, 2024
|
Jul 3 |
AbbVie: A Hold Again (Rating Downgrade)
|
Jul 2 |
7 Dividend Aristocrats That Will Have Investors in High-Yield Heaven
|
Jul 2 |
With 72% ownership, AbbVie Inc. (NYSE:ABBV) boasts of strong institutional backing
|
Jul 2 |
AbbVie to Host Second-Quarter 2024 Earnings Conference Call
|
Jul 2 |
3 Under-the-Radar Biotech Stocks With Blockbuster Potential
|
Jul 1 |
3 Retirement All-Stars for Steady Growth and Income
|
Jul 1 |
2 High-Yielding Healthcare Stocks to Buy With $1,000 in July
|
Jul 1 |
AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use
|
Jul 1 |
AbbVie names Robert A. Michael to CEO role
|